Provided by Tiger Trade Technology Pte. Ltd.

Adial Pharmaceuticals

3.97
-0.0200-0.50%
Post-market: 3.970.00000.00%16:10 EDT
Volume:5K
Turnover:19.68K
Market Cap:10.42M
PE:-0.22
High:4.05
Open:4.02
Low:3.92
Close:3.99
52wk High:10.75
52wk Low:1.31
Shares:2.63M
Float Shares:2.44M
Volume Ratio:0.16
T/O Rate:0.20%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-17.7100
EPS(LYR):-11.9306
ROE:-2011.64%
ROA:-40.02%
PB:-0.27
PE(LYR):-0.33

Loading ...

Adial Pharmaceuticals Posts Bigger-than-Expected Q2 Net Loss, Hurt by Acquisition Charges

Reuters
·
Aug 17

Adial Pharmaceuticals Q2 Net Income USD -52 Million

THOMSON REUTERS
·
Aug 17

Press Release: Adial Pharmaceuticals Reports 2026 Second Quarter Financial Results and Provides Business Update

Dow Jones
·
Aug 17

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Aug 17

Adial Pharma Faces Governance Risks and Major Dilution as 2026 Shareholder Vote Looms on Preferred Conversions and Warrants

TIPRANKS
·
Aug 16

Adial Pharmaceuticals Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 15

Adial Q2 Net Loss Widens to $51.99 Million from Year-Ago Quarter

Reuters
·
Aug 15

Adial Pharmaceuticals Plans Major Leadership and Board Transition

TIPRANKS
·
Aug 14

Adial Pharmaceuticals - as of Aug 10, Anticipates Termination of CEO Cary Claiborne After 2026 Annual Meeting

Reuters
·
Aug 14

Adial Pharmaceuticals - Anticipates Board Changes and Legacy Member Resignations After Stockholder Approval - SEC Filing

THOMSON REUTERS
·
Aug 14

Adial Pharmaceuticals - Anticipates Termination of CFO Vinay Shah After 2026 Annual Meeting - SEC Filing

THOMSON REUTERS
·
Aug 14

Adial Pharmaceuticals CEO Cary Claiborne Set to Depart After Sept. 17 Annual Meeting; CDO Matthew Davidson Slated to Succeed

Reuters
·
Aug 14

Adial Pharmaceuticals Announces Annual Shareholder Meeting

Reuters
·
Aug 11

Adial Pharmaceuticals Inc Expected to Post a Loss of $1.03 a Share - Earnings Preview

Reuters
·
Aug 08

Adial Pharmaceuticals Initiated at Buy by Alliance Global Partners

Dow Jones
·
Aug 04

Adial Pharmaceuticals Inc : Alliance Global Partners Initiates Coverage with Buy Rating; Price Target $11

THOMSON REUTERS
·
Aug 03

Coastlands Capital LP Reports $8,689 Adial Pharmaceuticals Common Share Purchase

Reuters
·
Jul 17

Coastlands Capital LP Reports Adial Pharmaceuticals Common Share Purchase Worth $32,613.87

Reuters
·
Jul 13

Major Investor Quietly Boosts Stake in Adial Pharmaceuticals

TIPRANKS
·
Jul 02

Coastlands Capital LP Buys 25,000 Adial Pharma Shares Worth $65,000

Reuters
·
Jul 01